Novo Nordisk partners with Anthropic to use Claude for drug discovery
Novo Nordisk said it is teaming up with Anthropic to deploy the Claude AI model to accelerate development of new medicines.
Novo Nordisk and Anthropic are teaming up to deploy the Claude artificial-intelligence model to help speed up the development of new medicines, in the latest partnership between the Wegovy maker and an AI lab. The companies said Wednesday their collaboration aims to accelerate drug discovery.